The prevalence rate of hepatitis B and hepatitis C co-infection in HIV positive patients in Mazandaran province, Iran

被引:0
作者
Babamahmoodi, Farhang
Gorji, Mohammad Ali Heidari [1 ]
Nasehi, Mohammad Mahdi
Delavarian, Leila [2 ]
机构
[1] Mazandaran Univ Med Sci, Dept Nursing, Sari, Iran
[2] Razi Hosp, Ghaemshahr, Iran
关键词
HIV; HCV; HBV; HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL-HEPATITIS; INFECTION; THERAPY; MORTALITY; DISEASE; IMPACT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To investigate the prevalence rate of hepatitis B (HVB) and hepatitis C (HCV) co-infection in HIV positives in Mazandaran province. Methods This descriptive cross-sectional study lasted from 2008 to 2010. The population of this study included 188 HIV positive persons confirmed to be infected by tests of ELISA I, II and western blood (WB) in the hospitals of Mazandaran University of Medical Sciences and Health Services. After getting permission, 5 cc venous blood samples were taken and drawn into a lab tube without citrate. Results Among the total of 188 HIV positive patients in Mazandaran province, only 80 patients were available, 62 had moved to other provinces, and 46 had died. Of the samples, 66 (82.5%) were males and 14 (17.5%) were females with the mean age of 37. Among the patients, nine (11.3%) were co-infected with HIV/HBV, 27(33.8%) with HIV/HCV, while 20(25%) were co-infected with HIV/HBV/HCV. Only one patient had travelled abroad and eight of them stated that they had used shared syringes. Conclusion The differences in the rate of HBV and HCV co-infection can be due to the epidemiologic conditions of viruses with different factors including different risk factors causing infection with these factors such as the rate of virus penetrating the body, the manner of penetration, patients' health condition, patients' culture, and their socio-economic condition, etc.
引用
收藏
页码:299 / 303
页数:5
相关论文
共 33 条
[1]  
Adhava V, 2002, LANCET INFECT DIS, V2, P293
[2]  
Alavi SM, 2007, PAK J MED SCI, V23, P510
[3]   Hepatitis C in patients with human immunodeficiency virus infection -: Diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues [J].
Bonacini, M ;
Puoti, M .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (22) :3365-3373
[4]   Management and treatment of hepatitis C virus infection in HIV-infected adults: Recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office [J].
Burgess, J ;
Davey, V ;
Raab, C ;
Deyton, LR ;
Wright, TL ;
Ho, SB ;
Garcia-Tsao, G ;
Dominitz, J ;
Tien, PC ;
Lampiris, H ;
Jensen, P ;
Currie, S .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (10) :2338-2354
[5]  
Christian B., 2010, 17 C RETR OPP INF CR
[6]  
Chung Raymond T., 2001, Antiviral Chemistry and Chemotherapy, V12, P73
[7]   Coinfection with hepatitis viruses and outcome of initial Antiretroviral regimens in previously naive HIV-Infected subjects [J].
De Luca, A ;
Bugarini, R ;
Lepri, AC ;
Puoti, M ;
Girardi, E ;
Antinori, A ;
Poggio, A ;
Pagano, G ;
Tositti, G ;
Cadeo, G ;
Macor, A ;
Toti, M ;
Monforte, AD .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (18) :2125-2132
[8]   HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C [J].
Di Martino, V ;
Thevenot, T ;
Boyer, N ;
Cazals-Hatem, D ;
Degott, C ;
Valla, D ;
Marcellin, P .
AIDS, 2002, 16 (03) :441-445
[9]   Hepatitis C and human immunodeficiency virus coinfections [J].
Dodig, M ;
Tavill, AS .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (05) :367-374
[10]   The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses [J].
Dore, GJ ;
Cooper, DA .
CURRENT OPINION IN INFECTIOUS DISEASES, 2001, 14 (06) :749-755